MedPath

The Glycaemic Response of Local Foods Using the Continuous Glucose Monitoring System

Not Applicable
Completed
Conditions
Diabetes
Interventions
Other: High glycemic index
Other: Low glycemic index
Registration Number
NCT03703544
Lead Sponsor
Clinical Nutrition Research Centre, Singapore
Brief Summary

This study is carried out to determine the effect of high and low GI of local foods using Continuous Glucose Monitoring System (CGMS™) on 24 hour blood glucose profiles.

Detailed Description

Glycemic Index (GI) is a method of classifying foods based on the food's ability to raise the blood glucose level. Low GI foods are recommended as Participants will have a lower impact on blood glucose concentrations. The research sets out to determine the effect of GI on 24 hour blood glucose profiles in healthy Chinese male participants. There will be two test sessions where participants will consume either a high or low GI breakfast, lunch, snack and dinner. Participants will take part in two test sessions (each spanning over 3 days and to monitor the participants' glycemic response using a Continuous Glucose Monitoring System (CGMS) throughout the period.This study specifically attempts to see how having high and low GI locally consumed meals impact on blood glucose.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
15
Inclusion Criteria
  • Chinese, male
  • Age between 21-50 years
  • Body mass index between 18 to 25 kg/m2
  • Normal blood pressure (<140/90 Hgmm)
  • Fasting blood glucose < 6 mmol/L
Exclusion Criteria
  • Current Smoker
  • Have any metabolic diseases (such as diabetes, hypertension etc)
  • Have known glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency)
  • have medical conditions and/or taking medications known to affect glycaemia (glucocorticoids, thyroid hormones, thiazide diuretics)
  • Have an ongoing infection or currently undergoing treatment at the time of screening
  • Known Chronic infection or known to suffer from or have previously suffered from or is a carrier of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV)• Have active Tuberculosis (TB) or currently receiving treatment for TB
  • Have intolerances or allergies to any foods
  • Partake in sports at the competitive and/or endurance levels

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
High glycemic indexHigh glycemic indexSubjects will consume locally consumed meals which are high glycemic index for breakfast, lunch snack and dinner will be provided.Participants' blood glucose will be monitored using the Continuous Glucose Monitor.
Low glycemic indexLow glycemic indexSubjects will consume locally consumed meals which are low glycemic index for breakfast, lunch snack and dinner will be provided. Participants' blood glucose will be monitored using the Continuous Glucose Monitor.
Primary Outcome Measures
NameTimeMethod
Daily blood glucose profile24 hours

The daily total blood glucose response is measured for each low and high GI treatment as the area under the curve over 24 hours using CGMS for breakfast, lunch, snack and dinner.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Nutrition Research Centre

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath